- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有100家主力机构披露2026-06-30报告期持股数据，持仓量总计2.22亿股，占流通A股30.28%
- 波段诊断：
-
技术面诊股
诊断结果：7.4技术面打败了88%的股票
技术面评分前10的股票
近期的平均成本为8.71元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为8.71元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"8.71","date":1792380963,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.10.19","stock":"1.50","trade":"0.26","ind":"0.13"},{"date":"2026.10.16","stock":"-2.48","trade":"-0.12","ind":"-0.12"},{"date":"2026.10.15","stock":"1.14","trade":"-1.40","ind":"-2.43"},{"date":"2026.10.14","stock":"-1.90","trade":"-0.46","ind":"-1.97"},{"date":"2026.10.13","stock":"1.36","trade":"-0.13","ind":"-0.25"},{"date":"2026.10.12","stock":"-1.12","trade":"-1.56","ind":"-2.03"},{"date":"2026.10.09","stock":"2.41","trade":"2.04","ind":"0.17"},{"date":"2026.10.08","stock":"-0.57","trade":"-0.69","ind":"-2.07"},{"date":"2026.09.30","stock":"2.34","trade":"1.21","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.12","trade":"-0.13","ind":"0.34"},{"date":"2026.09.28","stock":"0.47","trade":"-0.22","ind":"-3.44"},{"date":"2026.09.24","stock":"-1.73","trade":"-1.25","ind":"-2.34"},{"date":"2026.09.23","stock":"-1.81","trade":"-1.22","ind":"-0.64"},{"date":"2026.09.22","stock":"-1.56","trade":"-0.02","ind":"-0.05"},{"date":"2026.09.21","stock":"3.34","trade":"3.26","ind":"0.65"},{"date":"2026.09.18","stock":"0.93","trade":"0.53","ind":"1.72"},{"date":"2026.09.17","stock":"0.12","trade":"0.47","ind":"-0.33"},{"date":"2026.09.16","stock":"0.00","trade":"0.02","ind":"1.26"},{"date":"2026.09.15","stock":"-1.72","trade":"-1.87","ind":"-0.72"},{"date":"2026.09.14","stock":"2.10","trade":"1.60","ind":"-0.64"},{"date":"2026.09.11","stock":"-1.95","trade":"-2.01","ind":"-1.08"}]
九芝堂,深证成指,中药指数
压力支撑
该股压力位为8.65元，支撑位为8.51元。
[{"text":"\u538b\u529b\u4f4d","value":"8.65","date":1792339200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"8.51","date":1792339200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.1资金面打败了83%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体无进出。
更新时间：10月20日 12:52
| 机构今日流向(万元) | 1536.76 | 机构5日流向(万元) | 365.03 |
| 机构10日流向(万元) | 1864.96 | 机构20日流向(万元) | -1781.84 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加468.70万股，其中基金净增仓4家，主力净增仓75家，有一定的中长期投资价值。
截止2026-06-30，共100家主力机构（基金99家，一般法人1家），持仓量总计22234.09万股，占流通A股30.28%
其中，基金持仓与2025-12-31相比：
增仓：6家 ，增持 75.78万股
减仓：2家 ，减持 13.06万股
新出现在主力名单中：89家 ，持有1046.09万股
从主力名单中消失：14家 ，原持有640.11万股
其中，基金持仓与2025-12-31相比：
增仓：6家 ，增持 75.78万股
减仓：2家 ，减持 13.06万股
新出现在主力名单中：89家 ，持有1046.09万股
从主力名单中消失：14家 ，原持有640.11万股
消息面诊股
诊断结果：8消息面打败了98%的股票
今日有利好新闻的公司
近期利好消息较多且有重大利好，消息面发出积极信号。
更多>>个股资讯
- 医药生物三季报预告：细分赛道冷暖不一
2026-10-20 - AI赋能中药质控升级 上市公司加码数智化布局
2026-10-19 - 向“优”要增长，向“新”要利润 部分湘股率先发布前
2026-10-16 - 医保局出台多项创新扶持举措，探索价格预立项制度，布
2026-10-15 - 96家公司前三季度业绩预增
2026-10-15 - 101家上市公司三季度业绩预告出炉！4家归母净利润
2026-10-15 - 九芝堂前三季最高预盈3.12亿 3.1亿获吉象隆5
2026-10-14 - 一湘企今年前三季度净利润同比增长近5倍
2026-10-13 - 最高预增超5倍，药企三季报披露季开启
2026-10-13 - 九芝堂前三季度业绩大幅预增，连续八年股息率超3%
2026-10-13
消息列表
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-10-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-09-22 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-20 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-08-18 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-07-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 利好 | 分红转增 | 10派3元(含税) | 2026-03-27 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-03-18 |
| 一般消息 | 高管变动 | 因工作调整 | 2026-01-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 2条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.8行业面打败了96%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.10.19","price":"0.13","value":"0.26"},{"date":"2026.10.16","price":"-0.12","value":"-0.12"},{"date":"2026.10.15","price":"-2.43","value":"-1.40"},{"date":"2026.10.14","price":"-1.97","value":"-0.46"},{"date":"2026.10.13","price":"-0.25","value":"-0.13"},{"date":"2026.10.12","price":"-2.03","value":"-1.56"},{"date":"2026.10.09","price":"0.17","value":"2.04"},{"date":"2026.10.08","price":"-2.07","value":"-0.69"},{"date":"2026.09.30","price":"-0.11","value":"1.21"},{"date":"2026.09.29","price":"0.34","value":"-0.13"},{"date":"2026.09.28","price":"-3.44","value":"-0.22"},{"date":"2026.09.24","price":"-2.34","value":"-1.25"},{"date":"2026.09.23","price":"-0.64","value":"-1.22"},{"date":"2026.09.22","price":"-0.05","value":"-0.02"},{"date":"2026.09.21","price":"0.65","value":"3.26"},{"date":"2026.09.18","price":"1.72","value":"0.53"},{"date":"2026.09.17","price":"-0.33","value":"0.47"},{"date":"2026.09.16","price":"1.26","value":"0.02"},{"date":"2026.09.15","price":"-0.72","value":"-1.87"},{"date":"2026.09.14","price":"-0.64","value":"1.60"},{"date":"2026.09.11","price":"-1.08","value":"-2.01"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | ST万邦 | 26.17% | -16.32% | 5.1分 |
| 2 | 众生药业 | 19.45% | 8.29% | 6.8分 |
| 3 | 达仁堂 | 18.51% | 13.26% | 6.8分 |
| 4 | 华森制药 | 13.85% | 0.95% | 6.5分 |
| 5 | 马应龙 | 12.56% | 5.60% | 6.7分 |
| 6 | 羚锐制药 | 11.88% | 6.50% | 7.3分 |
| 8 | 云南白药 | 9.79% | 4.07% | 7.6分 |
| 10 | 同仁堂 | 8.25% | 3.68% | 6.6分 |
| 12 | 华润江中 | 7.79% | 4.47% | 7.4分 |
| 14 | 康缘药业 | 6.18% | 3.25% | 6.8分 |
| 16 | 广誉远 | 4.89% | 0.64% | 6.7分 |
| 18 | 天士力 | 4.43% | 2.93% | 6.7分 |
| 20 | 特一药业 | 3.63% | -1.77% | 4.5分 |
| 22 | 新光药业 | 3.32% | -2.52% | 4.7分 |
| 24 | 奇正藏药 | 2.62% | 0.31% | 6.1分 |
| 26 | 健民集团 | 2.55% | 1.91% | 6.4分 |
| 28 | 步长制药 | 2.07% | -0.34% | 6.2分 |
| 30 | 以岭药业 | 1.12% | 0.79% | 6.0分 |
| 32 | ST百灵 | 0.89% | -0.22% | 5.0分 |
| 34 | 太极集团 | -0.15% | -2.20% | 5.7分 |
| 36 | 红日药业 | -0.94% | -3.06% | 4.2分 |
| 38 | 葵花药业 | -1.05% | -1.57% | 5.3分 |
| 40 | 振东制药 | -1.78% | -4.24% | 4.3分 |
| 42 | 信邦制药 | -2.05% | -2.71% | 5.4分 |
| 44 | 上海凯宝 | -2.56% | -5.54% | 4.0分 |
| 46 | 新天药业 | -3.29% | -5.93% | 4.8分 |
| 48 | 益盛药业 | -3.74% | -2.76% | 4.8分 |
| 50 | 精华制药 | -4.24% | -9.23% | 4.7分 |
| 52 | - | -4.71% | -4.09% | 分 |
| 54 | ST葫芦娃 | -5.60% | -2.97% | 3.7分 |
| 56 | 康美药业 | -5.80% | -2.99% | 4.9分 |
| 58 | 粤万年青 | -6.43% | -7.70% | 4.3分 |
| 60 | 汉森制药 | -8.97% | -7.28% | 4.8分 |
| 62 | 三力制药 | -11.48% | -3.73% | 4.7分 |
| 64 | 陇神戎发 | -12.65% | -9.30% | 4.2分 |
| 66 | 康惠股份 | -14.49% | -3.49% | 5.0分 |
| 68 | *ST香雪 | -26.13% | -13.79% | 4.0分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 17/110 ， 25/110。
[{"date":"2026-06-30","value":"6.76","vol":"3.25"},{"date":"2026-03-31","value":"4.35","vol":"2.21"},{"date":"2025-12-31","value":"5.96","vol":"-2.33"},{"date":"2025-09-30","value":"4.09","vol":"4.80"},{"date":"2025-06-30","value":"3.89","vol":"4.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
6.76 | 4.35 | 5.96 | 4.09 | 3.89 |
| 行业(%) | 3.25 | 2.21 | -2.33 | 4.80 | 4.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"59.70","vol":"53.70"},{"date":"2026-03-31","value":"60.59","vol":"55.05"},{"date":"2025-12-31","value":"59.93","vol":"52.85"},{"date":"2025-09-30","value":"59.80","vol":"53.29"},{"date":"2025-06-30","value":"59.35","vol":"53.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
59.70 | 60.59 | 59.93 | 59.80 | 59.35 |
| 行业(%) | 53.70 | 55.05 | 52.85 | 53.29 | 53.82 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/110 ， 6/110。
[{"date":"2026-06-30","value":"29.08","vol":"-9.08"},{"date":"2026-03-31","value":"20.80","vol":"-5.58"},{"date":"2025-12-31","value":"-5.99","vol":"-6.76"},{"date":"2025-09-30","value":"-21.13","vol":"-7.84"},{"date":"2025-06-30","value":"-24.71","vol":"-7.78"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
29.08 | 20.80 | -5.99 | -21.13 | -24.71 |
| 行业(%) | -9.08 | -5.58 | -6.76 | -7.84 | -7.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"74.01","vol":"-101.51"},{"date":"2026-03-31","value":"41.53","vol":"1.06"},{"date":"2025-12-31","value":"2.96","vol":"-80.25"},{"date":"2025-09-30","value":"-36.94","vol":"-2.78"},{"date":"2025-06-30","value":"-29.71","vol":"2.25"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
74.01 | 41.53 | 2.96 | -36.94 | -29.71 |
| 行业(%) | -101.51 | 1.06 | -80.25 | -2.78 | 2.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/110 ， 45/110。
[{"date":"2026-06-30","value":"0.30","vol":"0.22"},{"date":"2026-03-31","value":"0.17","vol":"0.12"},{"date":"2025-12-31","value":"0.42","vol":"0.47"},{"date":"2025-09-30","value":"0.32","vol":"0.35"},{"date":"2025-06-30","value":"0.25","vol":"0.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.30 | 0.17 | 0.42 | 0.32 | 0.25 |
| 行业(次) | 0.22 | 0.12 | 0.47 | 0.35 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.73","vol":"1.14"},{"date":"2026-03-31","value":"0.43","vol":"0.59"},{"date":"2025-12-31","value":"0.89","vol":"2.34"},{"date":"2025-09-30","value":"0.68","vol":"1.72"},{"date":"2025-06-30","value":"0.54","vol":"1.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.73 | 0.43 | 0.89 | 0.68 | 0.54 |
| 行业(次) | 1.14 | 0.59 | 2.34 | 1.72 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 6/110 ， 42/110。
[{"date":"2026-06-30","value":"54.09","vol":"20.65"},{"date":"2026-03-31","value":"11.80","vol":"5.83"},{"date":"2025-12-31","value":"19.15","vol":"30.77"},{"date":"2025-09-30","value":"26.98","vol":"10.53"},{"date":"2025-06-30","value":"34.30","vol":"22.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 54.09 | 11.80 | 19.15 | 26.98 | 34.30 |
| 行业 | 20.65 | 5.83 | 30.77 | 10.53 | 22.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.78","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.31","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.47","vol":"1.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.78 | - | 0.31 | - | 0.47 |
| 行业 | 0.88 | 0.00 | 1.00 | 0.00 | 1.03 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/110 ， 34/110。
[{"date":"2026-06-30","value":"2.34","vol":"3.10"},{"date":"2026-03-31","value":"2.40","vol":"2.97"},{"date":"2025-12-31","value":"2.38","vol":"2.94"},{"date":"2025-09-30","value":"2.66","vol":"3.09"},{"date":"2025-06-30","value":"2.57","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.34 | 2.40 | 2.38 | 2.66 | 2.57 |
| 行业 | 3.10 | 2.97 | 2.94 | 3.09 | 2.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.58","vol":"2.34"},{"date":"2026-03-31","value":"1.68","vol":"2.23"},{"date":"2025-12-31","value":"1.50","vol":"2.15"},{"date":"2025-09-30","value":"1.74","vol":"2.24"},{"date":"2025-06-30","value":"1.71","vol":"2.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.58 | 1.68 | 1.50 | 1.74 | 1.71 |
| 行业 | 2.34 | 2.23 | 2.15 | 2.24 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 38/110 ， 35/110。
[{"date":"2026-06-30","value":"25.07","vol":"32.07"},{"date":"2026-03-31","value":"25.09","vol":"31.94"},{"date":"2025-12-31","value":"24.33","vol":"32.43"},{"date":"2025-09-30","value":"22.77","vol":"31.59"},{"date":"2025-06-30","value":"23.45","vol":"32.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.07 | 25.09 | 24.33 | 22.77 | 23.45 |
| 行业(%) | 32.07 | 31.94 | 32.43 | 31.59 | 32.45 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.38","vol":"0.68"},{"date":"2026-03-31","value":"0.37","vol":"0.66"},{"date":"2025-12-31","value":"0.36","vol":"0.67"},{"date":"2025-09-30","value":"0.31","vol":"0.76"},{"date":"2025-06-30","value":"0.32","vol":"0.75"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.38 | 0.37 | 0.36 | 0.31 | 0.32 |
| 行业(%) | 0.68 | 0.66 | 0.67 | 0.76 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"3.58","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.16","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.23","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.04","blueLineValue":"0.35","type":"YC"}]